Urokinase receptor (CD87) regulates leukocyte recruitment via β2 integrins in vivo

被引:253
作者
May, AE
Kanse, SM
Lund, LR
Gisler, RH
Imhof, BA
Preissner, KT
机构
[1] Max Planck Inst, Haemostasis Res Unit, Kerckhoff klin, D-61231 Bad Nauheim, Germany
[2] Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark
[3] Basel Inst Immunol, CH-4001 Basel, Switzerland
[4] Ctr Med Univ Geneva, Dept Pathol, CH-1211 Geneva 4, Switzerland
关键词
leukocyte; endothelial cells; urokinase receptor; beta(2) integrin; inflammation;
D O I
10.1084/jem.188.6.1029
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The urokinase receptor (CD87; uPAR) is found in close association with beta(2) integrins on leukocytes. We studied the functional consequence of this association for leukocyte adhesion and migration. In vivo, the beta(2) integrin-dependent recruitment of leukocytes to the inflamed peritoneum of uPAR-deficient mice was significantly reduced as compared with wild-type animals. In vitro, beta(2) integrin-mediated adhesion ofleukocytes to endothelium was lost upon removal of uPAR from the leukocyte surface by phosphatidyl-inositol-specific phospholipase C. Leukocyte adhesion was reconstituted when soluble intact uPAR, but not a truncated form lacking the uPA-binding domain, was allowed to reassociate with the cell surface, uPAR ligation with a monoclonal antibody induced adhesion of monocytic cells and neutrophils to vascular endothelium by six- to eightfold, whereas ligation with inactivated uPA significantly reduced cell-to-cell adhesion irrespective of the beta(2) integrin-stimulating pathway. These data indicate that beta(2) integrin-mediated leukocyte-endothelial cell interactions and recruitment to inflamed areas require the presence of uPAR and define a new phenotype for uPAR-deficient mice. Moreover, uPAR ligation differentially modulates leukocyte adhesion to endothelium and provides novel targets for therapeutic strategies in inflammation-related vascular pathologies.
引用
收藏
页码:1029 / 1037
页数:9
相关论文
共 54 条
[11]   REGULATION OF VASCULAR CELL-ADHESION MOLECULE-1 AND INTERCELLULAR-ADHESION MOLECULE-1 IN HUMAN VASCULAR SMOOTH-MUSCLE CELLS [J].
COUFFINHAL, T ;
DUPLAA, C ;
MOREAU, C ;
LAMAZIERE, JMD ;
BONNET, J .
CIRCULATION RESEARCH, 1994, 74 (02) :225-234
[12]   Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? [J].
Deng, G ;
Curriden, SA ;
Wang, SJ ;
Rosenberg, S ;
Loskutoff, DJ .
JOURNAL OF CELL BIOLOGY, 1996, 134 (06) :1563-1571
[13]   Generation and characterization of urokinase receptor-deficient mice [J].
Dewerchin, M ;
VanNuffelen, A ;
Wallays, G ;
Bouche, A ;
Moons, L ;
Carmeliet, P ;
Mulligan, RC ;
Collen, D .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (03) :870-878
[14]   INTERACTION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) WITH ITS CELLULAR RECEPTOR (U-PAR) INDUCES PHOSPHORYLATION ON TYROSINE OF A 38 KDA PROTEIN [J].
DUMLER, I ;
PETRI, T ;
SCHLEUNING, WD .
FEBS LETTERS, 1993, 322 (01) :37-40
[15]   Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans - A murine transgenic model [J].
Gyetko, MR ;
Chen, GH ;
McDonald, RA ;
Goodman, R ;
Huffnagle, GB ;
Wilkinson, CC ;
Fuller, JA ;
Toews, GB .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (08) :1818-1826
[16]   THE UROKINASE RECEPTOR IS REQUIRED FOR HUMAN MONOCYTE CHEMOTAXIS IN-VITRO [J].
GYETKO, MR ;
TODD, RF ;
WILKINSON, CC ;
SITRIN, RG .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (04) :1380-1387
[17]   STRUCTURE AND FUNCTION OF ADHESION RECEPTORS IN LEUKOCYTE TRAFFICKING [J].
HOGG, N ;
BERLIN, C .
IMMUNOLOGY TODAY, 1995, 16 (07) :327-330
[18]  
HOYERHANSEN G, 1992, J BIOL CHEM, V267, P18224
[19]   CULTURE OF HUMAN ENDOTHELIAL CELLS DERIVED FROM UMBILICAL VEINS - IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGICAL CRITERIA [J].
JAFFE, EA ;
NACHMAN, RL ;
BECKER, CG ;
MINICK, CR .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (11) :2745-2756
[20]  
KANSE SM, 1995, LAB INVEST, V72, P376